These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1973558)

  • 1. Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
    Horváth E; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():145-6. PubMed ID: 1973558
    [No Abstract]   [Full Text] [Related]  

  • 2. GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile.
    Jaszlits L; Rabloczky G; Csókás G; Bódi I; Kürthy M; Horváth E; Kovács A; Jednákovits A; Arányi P; Mátyus P
    Acta Physiol Hung; 1990; 75 Suppl():155-6. PubMed ID: 1973559
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular and cardiac electrophysiological activity of GYKI-12 743 in isolated tissue preparations.
    Jednákovits A; Kovács A; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():157-8. PubMed ID: 1973560
    [No Abstract]   [Full Text] [Related]  

  • 4. GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
    Rabloczky G; Jaszlits L; Horváth E
    Acta Physiol Hung; 1991; 77(3-4):257-67. PubMed ID: 1684485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical effects of GYKI-12 743.
    Bakonyi A; Tömösközi Z; Heiczman A; Horváth EJ; Arányi P; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():19-20. PubMed ID: 2164749
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of some WB4101 analogues bearing a naphthodioxanic nucleus.
    Castagnino E; Strappaghetti G; Corsano S; Gallucci P; Brasili L; Giardinà D
    Farmaco Sci; 1984 Jul; 39(7):569-74. PubMed ID: 6148262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and alpha-adrenolytic activities of 2-(1,4-benzodioxan-2-yl- methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives].
    Glusa E; Grüner H; Hagen A; Lohmann D; Foken H
    Pharmazie; 1990 Jun; 45(6):408-10. PubMed ID: 1976262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane].
    Staneva D; Spasov V; Ivanov D
    Eksp Med Morfol; 1984; 23(2):87-91. PubMed ID: 6147242
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on receptor interaction for the alpha-antagonist WB 4101.
    Kapur H; Green PN; Mottram DR
    J Pharm Pharmacol; 1979 Mar; 31(3):188-9. PubMed ID: 34700
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of idazoxan on tachycardia following electric stimulation of the thoracic sympathetic chain in the rat].
    Dabiré H; Fournier B; Schmitt H
    C R Seances Soc Biol Fil; 1986; 180(2):170-3. PubMed ID: 2877721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor interaction for the alpha-antagonist WB4101 (2(N[2,6-dimethyoxyphenoxyethyl])amino-methyl-1,4-benzodioxane).
    Kapur H; Mottram DR; Green PN
    J Pharm Pharmacol; 1978 Apr; 30(4):259-60. PubMed ID: 24721
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of WB4101, and other alpha-adrenoceptor antagonists, on 5-hydroxytryptamine receptors.
    Kapur H; Mottram DR
    J Pharm Pharmacol; 1979 May; 31(5):337-8. PubMed ID: 37307
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.
    Massingham R; Dubocovich ML; Shepperson NB; Langer SZ
    J Pharmacol Exp Ther; 1981 May; 217(2):467-74. PubMed ID: 6112260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of piperoxan and 2-(2-imidazolinyl)-1, 4-benzodioxane (170 150) on pre- and postsynaptic receptors in the rat].
    Mouillé P; Dabiré H; Fournier B; Schmitt H
    J Pharmacol; 1982; 13(3):389-97. PubMed ID: 6290793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of rausedyl and pyrroxan on autoregulation of cerebral circulation].
    Gaevyĭ MD; Pogorelyĭ VE
    Biull Eksp Biol Med; 1983 Jul; 96(7):56-9. PubMed ID: 6135465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychophysiologic aspect of regulating dyadic interpersonal interaction].
    Medvedev VI; Zav'ialova EK; Ovchinnikov BV; Posokhova ST
    Fiziol Cheloveka; 1986; 12(5):754-60. PubMed ID: 2880779
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
    Yamada S; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):176-85. PubMed ID: 6109014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.